These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 168261)

  • 1. Analysis of specificity of poliovirus inhibitors with inhibitor-resistant mutants of a strain of type 1 poliovirus.
    Hashimoto N
    J Immunol; 1975 Aug; 115(2):569-74. PubMed ID: 168261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of specificity of antibodies contained in antiserum against poliovirus with mutants resistant to inhibitors in equine serum.
    Urasawa S; Urasawa T; Kanamitsu M
    J Immunol; 1974 Aug; 113(2):537-42. PubMed ID: 4367633
    [No Abstract]   [Full Text] [Related]  

  • 3. Further studies of specificity of antibodies contained in antiserum against poliovirus.
    Urasawa S; Urasawa T; Kanamitsu M
    Jpn J Microbiol; 1976 Feb; 20(1):11-6. PubMed ID: 178940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
    Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
    Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivity of neutralizing antibodies with different specificities to H particles of poliovirus.
    Urasawa T; Urasawa S; Taniguchi K
    Microbiol Immunol; 1979; 23(7):651-7. PubMed ID: 228166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of type 1 poliovirus neutralization epitopes.
    Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
    Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen chimaeras of poliovirus as potential new vaccines.
    Burke KL; Dunn G; Ferguson M; Minor PD; Almond JW
    Nature; 1988 Mar; 332(6159):81-2. PubMed ID: 2450279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of poliovirus antigens and antibodies: microindirect haemagglutination and haemagglutination inhibition tests for poliovirus types I, II, and III.
    Esposito JJ
    Microbios; 1976; 16(63):29-36. PubMed ID: 194134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of naturally occurring poliovirus-reactive immunoglobulins in bovine and equine sera.
    Urasawa S; Urasawa T; Ishizawa F; Taniguchi K
    Jpn J Med Sci Biol; 1987 Apr; 40(2):61-74. PubMed ID: 2828725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the immune response of the rabbit to virulent and attenuated strains of type 1 poliovirus.
    Gaudin OG; Viac J; Thouvenot D; Sohier R
    Bull World Health Organ; 1974; 50(6):479-5. PubMed ID: 4376464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.
    Taniguchi K; Urasawa S; Urasawa T
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2803-8. PubMed ID: 6198442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic variation of poliovirus caused by antibody components with different specificities.
    Urasawa S; Ishizawa F; Urasawa T
    Microbiol Immunol; 1977; 21(6):299-307. PubMed ID: 198635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S
    J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of equine herpesvirus-1 antigen and the specific antibody by enzyme-linked immunosorbent assay.
    Dutta SK; Talbot NC; Myrup AC
    Am J Vet Res; 1983 Oct; 44(10):1930-4. PubMed ID: 6314855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
    Ferguson M; Minor PD; Magrath DI; Schild GC
    Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor.
    Harber J; Bernhardt G; Lu HH; Sgro JY; Wimmer E
    Virology; 1995 Dec; 214(2):559-70. PubMed ID: 8553558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the antigenic variation in poliovirus type 1. Selection and analysis of variant strains with monoclonal antibodies by neutralization.
    Thibodeau L; Lacroix M; Lecomte J; Fauvel M
    Dev Biol Stand; 1984; 57():157-63. PubMed ID: 6084606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of neutralizing antibodies by type 1 poliovirus VP1 capsid polypeptide.
    Crainic R; Blondel B; Horaud F
    Dev Biol Stand; 1983; 55():185-9. PubMed ID: 6329856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revertants of poliovirus escape mutants: new insights into antigenic structures.
    Ketterlinus R; Wiegers K; Dernick R
    Virology; 1993 Feb; 192(2):525-33. PubMed ID: 8380664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain differentiation of polioviruses with monoclonal antibodies.
    Osterhaus AD; van Wezel AL; Stegmann AJ; van Asten JA; Hazendonk AG
    Dev Biol Stand; 1984; 57():135-9. PubMed ID: 6098494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.